Abstract
A general model of an imperfect vaccine for a childhood disease is presented and the effects of different types of vaccine failure on transmission were investigated using models that consider both homogeneous and age-specific mixing. The models are extensions of the standard SEIR equations with an additional vaccinated component that allows for five different vaccine parameters: three types of vaccine failure in decreasing susceptibility to infection via failure in degree (“leakiness”), take (“all-or-nothingness”) and duration (waning of vaccine-derived immunity); one parameter reflecting the relative reduction in infectiousness of vaccinated individuals who get infected; and one parameter that reflects the relative reduction in reporting probability of vaccinated individuals due to a possible reduction in severity of symptoms. Only the first four parameters affect disease transmission (as measured by the basic reproduction number). The reduction in transmission due to vaccination is different for age-structured models than for homogeneous models. Notably, if the vaccine exhibits waning protection this could be larger for an age-structured model with high contact rates between young children who are still protected by the vaccine and lower contact rates between adults for whom protection might have already waned. Analytic expressions for age-specific “vaccine impacts” were also derived. The overall vaccine impact is bounded between the age-specific impact for the oldest age class and that of the youngest age class.
Similar content being viewed by others
References
Diekmann O, Heesterbeek JAP, Roberts MG (2010) The construction of next-generation matrices for compartmental epidemic models. J R Soc Interface 7(47):873–885. doi:10.1098/rsif.2009.0386. http://rsif.royalsocietypublishing.org/content/7/47/873
Farrington CP (2003) On vaccine efficacy and reproduction numbers. Math Biosci 185:89–109. doi:10.1016/S0025-5564(03)00061-0
Feng Z, Hill AN, Smith PJ, Glasser JW (2015) An elaboration of theory about preventing outbreaks in homogeneous populations to include heterogeneity or preferential mixing 386:177–187
Gomes MGM, Lipsitch M, Wargo AR, Kurath G, Rebelo C, Medley GF, Coutinho A (2014) A missing dimension in measures of vaccination impacts. PLOS Pathog 10(3):1–3. doi:10.1371/journal.ppat.1003849
Gomes MGM, White LJ, Medley GF (2004) Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives. J Theor Biol 228:539–549. doi:10.1016/j.jtbi.2004.02.015
Halloran ME, Haber M, Longini IM (1992) Interpreation and estimation of vaccine effiicacy under heterogeneity. Am J Epidemiol 136(3):328–343. doi:10.1016/0025-5564(93)90028-9
Heffernan JM, Keeling MJ (2009) Implications of vaccination and waning immunity. Proc R Soc Lond B 276(1664):2071–2080. doi:10.1098/rspb.2009.0057
Magpantay FMG, Domenech de Celles M, Rohani P, King AA (2016) Pertussis immunity and epidemiology: mode and duration of vaccine-induced immunity. Parasitology 143:835–849. doi:10.1017/S0031182015000979
Magpantay FMG, Riolo MA, Domenech de Cellès M, King AA, Rohani P (2014) Epidemiological consequences of imperfect vaccines for immunizing infections. SIAM J Appl Math 74(6):1810–1830. doi:10.1137/140956695
McLean A, Blower SM (1993) Imperfect vaccines and herd immunity to HIV. Proc R Soc Lond B 253:9–13. doi:10.1098/rspb.1993.0075
McLean AR (1998) Vaccines and their impact on the control of disease. Br Med Bull 54(3):545–556. doi:10.1093/oxfordjournals.bmb.a011709
Shim E, Galvani AP (2012) Distinguishing vaccine efficacy and effectiveness. Vaccine 30:6700–6705
van den Driessche P, Watmough J (2008) Further notes on the basic reproduction number. In: Brauer F, van den Driessche P, Wu J (eds) Mathematical epidemiology, chap 6. Springer, Berlin, pp 159–178
Acknowledgements
The author thanks M. Domenech de Cellès, A.A. King and P. Rohani for their helpful insights. This work is supported by the Natural Sciences and Engineering Research Council of Canada, the National Institutes of Health (Grant No. R01AI101155) and by MIDAS, National Institute of General Medical Sciences (Grant No. U54-GM111274).
Author information
Authors and Affiliations
Corresponding author
Additional information
National Institutes of Health (Grant No. R01AI101155) and MIDAS, National Institute of General Medical Sciences, University of Manitoba and NSERC Canada.
Rights and permissions
About this article
Cite this article
Magpantay, F.M.G. Vaccine impact in homogeneous and age-structured models. J. Math. Biol. 75, 1591–1617 (2017). https://doi.org/10.1007/s00285-017-1126-5
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00285-017-1126-5